New drug pricing reform adviser named at HHS

Modern Healthcare: HHS announced Thursday that John O'Brien will succeed the late Dan Best in heading the agency's prescription drug pricing reform efforts.

O'Brien, a former health insurance executive, will serve as senior adviser for drug pricing reform to HHS Secretary Alex Azar. He previously served as Azar's adviser for health reform and drug pricing, as well as deputy assistant secretary for health policy within the Office of the Assistant Secretary for Planning and Evaluation.

Read article